trending Market Intelligence /marketintelligence/en/news-insights/trending/owh4xownyeq_k-zcj7uzia2 content esgSubNav
In This List

Report: Aurora Cannabis wins shares needed for C$1.1B CanniMed buy

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Report: Aurora Cannabis wins shares needed for C$1.1B CanniMed buy

Canadian marijuana producer Aurora Cannabis Inc. has won the shareholders support required for its C$1.1 billion acquisition of CanniMed Therapeutics Inc., Bloomberg News reported, citing anonymous sources.

Vancouver, British Columbia-based Aurora had initially made a hostile bid that valued Saskatoon, Saskatchewan-based CanniMed at C$24 a share in November 2017.

In January, the companies reached a deal once Aurora sweetened the offer to C$43 per share.

People familiar with the matter told the news outlet that more than two-thirds of CanniMed shareholders tendered their shares before the March 9 deadline, clearing the path for the deal.

Aurora spokesman Cam Battley told Bloomberg that the company is "still satisfying material conditions" of the deal.